These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 9750654)

  • 1. [Ketamine from an anticonvulsant perspective].
    Mion G; Rüttimann M
    Ann Fr Anesth Reanim; 1997; 16(8):1045-6. PubMed ID: 9750654
    [No Abstract]   [Full Text] [Related]  

  • 2. Role of ketamine in convulsions.
    Khanna N; Bhalla S
    Indian J Med Sci; 1999 Nov; 53(11):475-80. PubMed ID: 10862269
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ketamine continuous infusion for refractory status epilepticus in a patient with anticonvulsant hypersensitivity syndrome.
    Esaian D; Joset D; Lazarovits C; Dugan PC; Fridman D
    Ann Pharmacother; 2013 Nov; 47(11):1569-76. PubMed ID: 24259603
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ketamine: relief from chronic pain through actions at the NMDA receptor?
    Meller ST
    Pain; 1996 Dec; 68(2-3):435-6. PubMed ID: 9121834
    [No Abstract]   [Full Text] [Related]  

  • 5. Reply to S.T. Meller: Ketamine: relief from chronic pain through actions at the NMDA receptor.
    Eide PK; Stubhaug A; Breivik H; Oye I
    Pain; 1997 Aug; 72(1-2):289-91. PubMed ID: 9272819
    [No Abstract]   [Full Text] [Related]  

  • 6. Critical Appraisal of Existing Ketamine Trials: Existing Limitations and Limited Applicability for Treatment.
    Zhang MW; Ho R
    Am J Psychiatry; 2016 Apr; 173(4):431. PubMed ID: 27035535
    [No Abstract]   [Full Text] [Related]  

  • 7. N-methyl-D-aspartate glutamate receptor antagonists and the promise of rapid-acting antidepressants.
    Krystal JH
    Arch Gen Psychiatry; 2010 Nov; 67(11):1110-1. PubMed ID: 21041611
    [No Abstract]   [Full Text] [Related]  

  • 8. Ketamine for restless legs syndrome.
    Friedman R
    Anesth Analg; 2003 Apr; 96(4):1238-1239. PubMed ID: 12651704
    [No Abstract]   [Full Text] [Related]  

  • 9. Response to Zhang and Ho: Addressing Ketamine's Use in Depression.
    Newport DJ; Nemeroff CB
    Am J Psychiatry; 2016 Apr; 173(4):431-2. PubMed ID: 27035536
    [No Abstract]   [Full Text] [Related]  

  • 10. Ketamine analgesia, NMDA receptors and the gates of perception.
    Oye I
    Acta Anaesthesiol Scand; 1998 Aug; 42(7):747-9. PubMed ID: 9698947
    [No Abstract]   [Full Text] [Related]  

  • 11. NMDA antagonist treatment of depression.
    Williams NR; Schatzberg AF
    Curr Opin Neurobiol; 2016 Feb; 36():112-7. PubMed ID: 26687375
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Exploiting N-methyl-d-aspartate channel blockade for a rapid antidepressant response in major depressive disorder.
    Blier P
    Biol Psychiatry; 2013 Aug; 74(4):238-9. PubMed ID: 23885752
    [No Abstract]   [Full Text] [Related]  

  • 13. Neuroprotection by ketamine: a review of the experimental and clinical evidence.
    Hudetz JA; Pagel PS
    J Cardiothorac Vasc Anesth; 2010 Feb; 24(1):131-42. PubMed ID: 19640746
    [No Abstract]   [Full Text] [Related]  

  • 14. NMDA receptor blockade prevents nitroglycerin-induced headaches.
    Roffey P; Mikhail M; Thangathurai D
    Headache; 2001; 41(7):733. PubMed ID: 11554966
    [No Abstract]   [Full Text] [Related]  

  • 15. Ketamine followed by memantine for the treatment of major depression.
    Kollmar R; Markovic K; Thürauf N; Schmitt H; Kornhuber J
    Aust N Z J Psychiatry; 2008 Feb; 42(2):170. PubMed ID: 18197514
    [No Abstract]   [Full Text] [Related]  

  • 16. Ketamine as an alternative treatment for treatment-resistant depression.
    Dowben JS; Grant JS; Keltner NL
    Perspect Psychiatr Care; 2013 Jan; 49(1):2-4. PubMed ID: 23293991
    [No Abstract]   [Full Text] [Related]  

  • 17. mGlu1 and mGlu5 receptor antagonists lack anticonvulsant efficacy in rodent models of difficult-to-treat partial epilepsy.
    Löscher W; Dekundy A; Nagel J; Danysz W; Parsons CG; Potschka H
    Neuropharmacology; 2006 Jun; 50(8):1006-15. PubMed ID: 16563443
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sustained antidepressant response to ketamine.
    Atigari OV; Healy D
    BMJ Case Rep; 2013 Aug; 2013():. PubMed ID: 23960151
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Local treatment with the N-methyl-D-aspartate receptor antagonist ketamine, inhibit development of secondary hyperalgesia in man by a peripheral action.
    Warncke T; Jørum E; Stubhaug A
    Neurosci Lett; 1997 May; 227(1):1-4. PubMed ID: 9178844
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Opioid-induced hyperalgesia: low-dose ketamine does work for some orthopaedic problems already.
    Griffiths R
    Br J Anaesth; 2010 May; 104(5):660-1; author reply 661. PubMed ID: 20400615
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.